Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its insiders. Mind Medicine Inc shares valued at $20,930 were purchased by GRYSKA DAVID W on Aug 23 ’24. At $5.98 per share, GRYSKA DAVID W acquired 3,500 shares. The insider’s holdings grew to 17,351 shares worth approximately $0.11 million following the completion of this transaction.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Also, Barrow Robert purchased 500 shares, netting a total of over 3,155 in proceeds. Following the buying of shares at $6.31 each, the insider now holds 565,043 shares.
Before that, Barrow Robert had added 500 shares to its account. In a trade valued at $3,060, the Chief Executive Officer bought Mind Medicine Inc shares for $6.12 each. Upon closing the transaction, the insider’s holdings increased to 500 shares, worth approximately $3.5 million.
As published in their initiating research note from ROTH MKM on July 24, 2024, Mind Medicine Inc [MNMD] has been a Buy and the price target has been revised to $36. Analysts at Robert W. Baird started covering the stock with ‘”an Outperform”‘ outlook in a report released in late May. As of April 15, 2024, Leerink Partners has initiated its “an Outperform” rating for MNMD. Earlier on December 05, 2023, Canaccord Genuity initiated its rating. Their recommendation was “a Buy” for MNMD stock.
Analyzing MNMD Stock Performance
During the last five days, there has been a surge of approximately 0.73%. Over the course of the year, Mind Medicine Inc shares have jumped approximately 68.85%. Shares of the company reached a 52-week high of $12.22 on 04/04/24 and a 52-week low of $3.49 on 01/19/24. A 50-day SMA is recorded $7.17, while a 200-day SMA reached $6.77. Nevertheless, trading volume fell to 0.77 million shares from 0.37 million shares the previous day.
Support And Resistance Levels for Mind Medicine Inc (MNMD)
According to the 24-hour chart, there is a support level at 6.00, which, if violated, would cause prices to drop to 5.82. In the upper region, resistance lies at 6.32. The next price resistance is at 6.47. RSI (Relative Strength Index) is 45.03 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at -0.02, which suggests the price will decrease in the coming days. Percent R is at 16.42%, indicating bullish price movement. Stochastics %K at holding indicates that the stock is to be held.
